Sparrow Fund Management LP v. Mimedx Group, Inc.

Background

Sparrow Fund Management LP sued MiMedx Group, Inc. for defamation and malicious prosecution. The claims arose from an earlier lawsuit in which MiMedx alleged that Sparrow or its principals had made defamatory statements about MiMedx through anonymous blog posts published under the name Aurelius Value.

During discovery in this case, the parties agreed to a protective order governing information marked “Confidential.” The order limited the use of confidential discovery materials to this case. Sparrow later asked the court to remove the confidentiality designations from information it wanted to include in an amended complaint in a related California state-court action. The information primarily concerned MiMedx’s investigations into Aurelius Value’s identity.

The Court’s Analysis

The court first held that the protective order covered the challenged information. The order’s listed categories of confidential information were not exhaustive, and the court concluded that the order could reasonably cover commercially sensitive investigations into Aurelius Value’s identity. The court therefore proceeded on the assumption that the order applied to the documents and communications Sparrow identified.

The court then considered whether modifying the order was appropriate. It examined the order’s scope, its language, the level of judicial review before entry, and the nature of MiMedx’s reliance on it. Although the order’s language could reasonably have led MiMedx to expect that the information would not be disclosed to nonparties or the public, the order was a broad, stipulated “blanket” order. The court had not conducted a detailed good-cause review before entering it, and MiMedx would have needed to produce the investigation materials to support its defense even without the protective order. On balance, the court found that MiMedx had not reasonably relied on the order to preserve the information’s confidentiality.

The court also required MiMedx to show “good cause,” meaning a clearly defined, specific, and serious injury from disclosure. After reviewing the materials privately, the court found that MiMedx had not made that showing. The materials included emails about investigative tactics, objectives, leads, and efforts to identify Aurelius Value; invoices and descriptions of services by outside counsel and investigators; and a draft response to the Financial Industry Regulatory Authority concerning largely public statements. The court found no sufficient basis to conclude that disclosure of these materials would seriously harm MiMedx.

Ruling

Judge Katharine H. Parker granted Sparrow’s motion to de-designate the identified information. The documents discussed in the opinion were no longer “Confidential” under the protective order. The ruling concerned discovery confidentiality and whether the materials could be used in the related California action; it did not decide the underlying defamation or malicious-prosecution claims.